Bernie Sanders Takes Stand Against Corporate Greed in Drug Prices of Novo Nordisk's Ozempic and Wegovy
Addressing Corporate Greed in Drug Prices
U.S. Senator Bernie Sanders has publicly criticized the pharmaceutical giant Novo Nordisk for the skyrocketing prices of the diabetes medications Ozempic and Wegovy. Speaking before a panel, he emphasized that while American patients are forced to pay upwards of $900 monthly for these drugs, generic options could be produced for less than $100, following a recent study revealing manufacturing costs as low as $5 a month.
Senate Help Committee's Role
In conversations with major drug manufacturers, Sanders noted that lucrative profits could still be realized even with drastic price reductions. He calls on the Senate Help Committee to take decisive action against the practices of big pharma that perpetuate this corporate greed.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.